| |
| | John R. Eckardt, MD |
 | | Rinaldi, D.A., Burris, H.A., Dorr, F.A., Nelson, J., Fields, S.M., Kuhn, J.G., Eckardt, J.R., Lu, P., Woodworth, J.R., Corso, S.W., Von Hoff, D.D.: A phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, in patients with advanced solid tumors. |
 | | P., rinaldi, D., Kuhn, J.G., Ford, J., Ganapathi, R.: Measurement of tumor topoisomerase I and II levels during the sequential administration of topotecan and etoposide. |
 | | Rinaldi, D.A., Burris, H.A., Dorr, F.A., Nelson, J., Fields, S.M., Eckardt, J.R., Lu, P., Woodworth, J.R., Corso, S.W., Kuhn, J.G., Von Hoff, D.: A phase I evaluation of the novel thymidylate synthase inhibitor, LY231514, in patients with advanced solid tumors. |
| www.tcccr.com /about/physicians_eckardt.php (6938 words) |
|